---
figid: PMC7786519__13045_2020_1025_Fig2_HTML
figlink: pmc/articles/PMC7786519/figure/Fig2/
number: F2
caption: 'RAS/RAF/MEK/ERK signaling pathway. RTK: receptor tyrosine kinase; GRB: growth
  factor receptor bound protein; SOS: Son of Sevenless homolog; GDP: guanosine diphosphate;
  GTP: guanosine triphosphate; RAS: rat sarcoma viral oncogene; RAF: v-raf murine
  sarcoma viral oncogene; MEK: mitogen-activated protein kinase kinase; ERK: extracellular
  signal-regulated kinase; PI3K: phosphatidylinositol 3-kinase; AKT: protein kinase
  B; mTOR: mammalian target of rapamycin; NF-kB: nuclear factor-kB'
pmcid: PMC7786519
papertitle: MEK inhibitors for the treatment of non-small cell lung cancer.
reftext: Jing Han, et al. J Hematol Oncol. 2021;14:1.
pmc_ranked_result_index: '22868'
pathway_score: 0.9456925
filename: 13045_2020_1025_Fig2_HTML.jpg
figtitle: RAS/RAF/MEK/ERK signaling pathway
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7786519__13045_2020_1025_Fig2_HTML.html
  '@type': Dataset
  description: 'RAS/RAF/MEK/ERK signaling pathway. RTK: receptor tyrosine kinase;
    GRB: growth factor receptor bound protein; SOS: Son of Sevenless homolog; GDP:
    guanosine diphosphate; GTP: guanosine triphosphate; RAS: rat sarcoma viral oncogene;
    RAF: v-raf murine sarcoma viral oncogene; MEK: mitogen-activated protein kinase
    kinase; ERK: extracellular signal-regulated kinase; PI3K: phosphatidylinositol
    3-kinase; AKT: protein kinase B; mTOR: mammalian target of rapamycin; NF-kB: nuclear
    factor-kB'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - NRAS
  - GRB2
  - SOS1
  - SOS2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - MTOR
  - Dabrafenib
  - Encorafenib
  - GDP GTP
  - Vemurafenib
  - Trametinib
  - Binimetinib
  - Selumetinib
  - Cobimetinib
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Encorafenib
  source: ''
  identifier: ''
- word: GDP GTP
  source: MESH
  identifier: D006153
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Binimetinib
  source: MESH
  identifier: C581313
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: Cobimetinib
  source: MESH
  identifier: C574276
diseases: []
figid_alias: PMC7786519__F2
redirect_from: /figures/PMC7786519__F2
figtype: Figure
---
